1 INTRODUCTION      

    1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

2 Research Methodology 
    2.1 Research Methodology Steps 
    2.2 Secondary and Primary Research Methodology 
           2.2.1 Secondary Research
           2.2.2 Primary Research
                     2.2.2.1 Key Data From Primary Sources
                     2.2.2.2 Key Industry Insights
    2.3 Market Size Estimation Methodology 
           2.3.1 Market Data Validation and Triangulation
           2.3.2 Assumptions for the Study

3 Executive Summary 
    3.1 Introduction 
    3.2 Conclusion

4 Premium Insights 
    4.1 Genome Editing: Market Overview 
    4.2 Geographic Analysis: Genome Editing Market, By Application (2018) 
    4.3 Market Size, By Technology, 2019 vs 2025
    4.4 Market Size, By Application, 2019 vs 2025
    4.5 Market Size, By End User, 2019 vs 2025
    4.6 Geographical Snapshot of the Genome Editing Market

5 Market Overview 
    5.1 Introduction 
    5.2 Market Dynamics 
           5.2.1 Drivers
                     5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
                     5.2.1.2 High Prevalence Rate of Infectious Diseases and Cancer Among Patients
                     5.2.1.3 Technological Advancements
                     5.2.1.4 Increase in Demand for Synthetic Genes
                     5.2.1.5 Rise in Production of Genetically Modified Crops
                     5.2.1.6 Increasing Awareness About Genomics
                     5.2.1.7 New Product Launches By Industry Players
           5.2.2 Restraints
                     5.2.2.1 High Cost of Genomic Equipment
                     5.2.2.2 Adverse Public Perception Related to Genetic Research
           5.2.3 Opportunities
                     5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
                     5.2.3.2 Emerging Markets in Developing Countries
           5.2.4 Challenges
                     5.2.4.1 Off-Target Effect of CRISPR
                     5.2.4.2 Shortage of Trained Professionals

6 Global Genome Editing/Engineering Market, By Technology 
    6.1 Introduction 
    6.2 CRISPR 
    6.3 TALEN 
    6.4 ZFN 
    6.5 Antisense 
    6.6 Other Technologies

7 Global Genome Editing/Genome Engineering Market, By Application 
    7.1 Introduction 
    7.2 Cell Line Engineering 
    7.3 Animal Genetic Engineering 
    7.4 Plant Genetic Engineering 
    7.5 Other Applications

8 Global Genome Editing/Engineering Market, By End User
    8.1 Introduction 
    8.2 Biotechnology & Pharmaceutical Companies 
    8.3 Academic & Government Research Institutes 
    8.4 Contract Research Organizations

9 Genome Editing/Genome Engineering Market, By Region 
    9.1 Introduction 
    9.2 North America 
           9.2.1 U.S.
                     9.2.1.1 Development of Gene Therapy in the U.S.
                     9.2.1.2 Increasing Use of Gm Crops
                     9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the United States
                     9.2.1.4 Genome Editing Conferences in the U.S.
                     9.2.1.5 Rising Availability of Research Grants and Funding
                     9.2.1.6 Genome Editing Standards Workshop in the U.S.
                     9.2.1.7 Increasing Prevalence of Cancer
                     9.2.1.8 Strategic Developments in the U.S. Market
           9.2.2 Canada
                     9.2.2.1 Availability of Research Funding in Canada
                     9.2.2.2 Rising Incidence of Cancer
                     9.2.2.3 Gapp to Intensify Genomic R&D
    9.3 Europe 
           9.3.1 Conferences and Meetings in Europe
           9.3.2 U.K.
                     9.3.2.1 Increased Funds, and Grants By Government Bodies
                     9.3.2.2 100,000 Genomes Project in U.K.
           9.3.3 Germany
                     9.3.3.1 Availability of Funding for Life Science Research
                     9.3.3.2 Conferences/Meetings/ Symposiums/Workshops in Germany
                     9.3.3.3 RoE
                     9.3.3.4 Spain’s Focus on Research
                     9.3.3.5 Growth in the Italian Biotech and Pharma Sectors
                     9.3.3.6 Growing Research Investments in Sweden & Denmark
    9.4 Asia-Pacific 
           9.4.1 China
                     9.4.1.1 High Intensity of R&D Activities in China
                     9.4.1.2 Growing Focus of Global Companies on China
           9.4.2 Japan
                     9.4.2.1 Involvement of Industry Players in the Japanese Market: Significant Developments
                     9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
                     9.4.2.3 Focus on Cancer Research and Treatment
           9.4.3 India
                     9.4.3.1 Emergence of Local Players in India
                     9.4.3.2 Growth of the Pharmaceutical Industry in India
                     9.4.3.3 Development of Bio-Clusters to Boost India’s Biotechnology Industry
           9.4.4 RoAPAC
                     9.4.4.1 Australia: Availability of Financial Support for Research
                     9.4.4.2 Genome Asia 100k Initiative
                     9.4.4.3 Crop Research Initiatives in Asia
    9.5 RoW 
           9.5.1 Genetic Testing and Genomic Analysis in the Middle East
           9.5.2 Brazil: Investments in Research and Innovation Centers and Conferences & Workshops
           9.5.3 Rising Prevalence of Hiv, Cancer in Africa

10 Competitive Landscape 
     10.1 Overview 
     10.2 Market Share Analysis 
               10.2.1 Introduction
               10.2.2 Thermo Fisher Scientific, Inc.
               10.2.3 Merck KGaA
               10.2.4 Horizon Discovery Group PLC
     10.3 Competitive Situation and Trends 
               10.3.1 Agreements, Collaborations, and Partnerships
               10.3.2 Product & Service Launches
               10.3.3 Acquisitions
               10.3.4 Expansions
               10.3.5 Other Strategies
     10.4 Strategic Benchmarking

11 Company Profiles 

     11.1 Thermo Fisher Scientific, Inc. 
     11.2 Merck KGaA 
     11.3 Horizon Discovery Group PLC  
     11.4 Genscript USA Inc. 
     11.5 Sangamo Biosciences, Inc. 
     11.6 Integrated DNA Technologies, Inc. 
     11.7 Lonza Group Ltd. 
     11.8 New England Biolabs, Inc. 
     11.9 Origene Technologies, Inc. 
     11.10 Transposagen Biopharmaceuticals, Inc.